Suppr超能文献

双倍时间的光动力疗法治疗局限性脉络膜血管瘤:基于初始参数的功能和解剖结果。

Photodynamic therapy with double duration for circumscribed choroidal haemangioma: functional and anatomical results based on initial parameters.

机构信息

Department of Ophthalmology, Eberhard Karls University Tübingen, Tübingen, Germany.

出版信息

Clin Exp Ophthalmol. 2018 Jul;46(5):495-501. doi: 10.1111/ceo.13096. Epub 2017 Dec 6.

Abstract

IMPORTANCE

Pre-treatment symptoms longer than 12 months and foveal cystoid changes are indicators for poor anatomical and functional outcome after photodynamic therapy (PDT).

BACKGROUND

To evaluate the prognostic factors on the effectiveness of PDT with double duration for treatment of exudative circumscribed choroidal haemangioma.

DESIGN

Retrospective study.

PARTICIPANTS

Twenty-seven patients with symptomatic exudative circumscribed choroidal haemangioma treated with PDT.

METHODS

Clinical charts of patients with exudative circumscribed choroidal haemangioma treated with PDT were analysed with regard to visual acuity, duration of symptoms, subfoveal fluid, foveal cystoid changes and foveal thickness in optical coherence tomography.

MAIN OUTCOME MEASURES

Change of best-corrected visual acuity, sub- and intrafoveal fluid and foveal thickness measured with optical coherence tomography from baseline to last follow-up.

RESULTS

Mean visual acuity improved by 0.05 from 0.42 logMAR (standard deviation [SD] 0.34) to 0.37 logMAR (SD 0.47). In 70% of the patients, PDT stopped exudation and revealed a dry fovea. The recurrence or persistence of sub- or intrafoveal fluid was significantly associated with pre-therapeutic symptoms existing for more than 12 months (P = 0.046). Mean foveal thickness in optical coherence tomography decreased from 324 μm (SD 223 μm) to 209 μm (SD 109 μm).

CONCLUSIONS AND RELEVANCE

PDT proved to be a safe and effective treatment procedure for exudative circumscribed choroidal haemangioma in our series, with few side effects. We observed a more successful treatment with regard to anatomical and functional results in cases with pre-existing symptoms less than 12 months and in cases without pre-therapeutic foveal cystoid changes.

摘要

重要性

治疗前症状超过 12 个月和中心凹囊样改变是光动力疗法(PDT)后解剖和功能结局不良的指标。

背景

评估 PDT 双剂量治疗渗出性局限性脉络膜血管瘤的有效性的预后因素。

设计

回顾性研究。

参与者

27 例有症状的渗出性局限性脉络膜血管瘤患者接受 PDT 治疗。

方法

分析有渗出性局限性脉络膜血管瘤患者的临床病历,分析视力、症状持续时间、黄斑下积液、中心凹囊样改变和光学相干断层扫描(OCT)中的中心凹厚度。

主要观察指标

从基线到最后一次随访时最佳矫正视力、黄斑下和中心凹积液以及 OCT 测量的中心凹厚度的变化。

结果

平均视力从 0.42 对数视力(标准差[SD]0.34)提高到 0.37 对数视力(SD 0.47),提高了 0.05。在 70%的患者中,PDT 停止了渗出,并显示出干性黄斑。黄斑下或中心凹积液的复发或持续与治疗前存在超过 12 个月的症状(P=0.046)显著相关。OCT 测量的平均中心凹厚度从 324μm(SD 223μm)下降到 209μm(SD 109μm)。

结论

在我们的研究中,PDT 被证明是治疗渗出性局限性脉络膜血管瘤的一种安全有效的治疗方法,副作用较少。我们观察到,对于治疗前症状少于 12 个月和治疗前没有中心凹囊样改变的病例,在解剖和功能结果方面,治疗效果更为成功。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验